Nab-paclitaxel: An effective third-line chemotherapy in patients with advanced, unresectable gallbladder cancer
Background & objectives: Gallbladder (GBC) is an aggressive form of cancer and most patients present with advanced unresectable disease due to lack of early signs and symptoms. This retrospective study was conducted to present the treatment outcomes with three lines of chemotherapies in a subset...
Main Authors: | Vineet Talwar, Shubhra Raina, Varun Goel, Prasanta Dash, Dinesh C Doval |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Indian Journal of Medical Research |
Subjects: | |
Online Access: | http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2020;volume=152;issue=5;spage=475;epage=481;aulast=Talwar |
Similar Items
-
Long-Term Response to Gemcitabine, Cisplatin, and Nab-Paclitaxel Followed by Maintenance Therapy for Advanced Gallbladder Cancer: A Case Report and Literature Review
by: Ting Liu, et al.
Published: (2021-10-01) -
Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: does sequence matter?
by: Ursula M. Vogl, et al.
Published: (2019-01-01) -
Successful Treatment of Advanced Thymic Carcinoma with Carboplatin plus nab-Paclitaxel and Maintenance Monotherapy with nab-Paclitaxel: Two Case Reports
by: Tomoyuki Araya, et al.
Published: (2020-12-01) -
The role of nab-paclitaxel in the treatment of patients with metastatic breast cancer
by: M A Frolova
Published: (2016-09-01) -
nab-Paclitaxel for the treatment of pancreatic cancer
by: Kim G
Published: (2017-03-01)